Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bicycle Therapeutics (BCYC) Current Leases (2019 - 2025)

Bicycle Therapeutics' Current Leases history spans 7 years, with the latest figure at $205000.0 for Q4 2025.

  • For Q4 2025, Current Leases fell 96.15% year-over-year to $205000.0; the TTM value through Dec 2025 reached $205000.0, down 96.15%, while the annual FY2025 figure was $205000.0, 96.15% down from the prior year.
  • Current Leases reached $205000.0 in Q4 2025 per BCYC's latest filing, down from $5.2 million in the prior quarter.
  • In the past five years, Current Leases ranged from a high of $5.3 million in Q4 2024 to a low of $182000.0 in Q3 2024.
  • Average Current Leases over 5 years is $3.0 million, with a median of $3.0 million recorded in 2022.
  • Peak YoY movement for Current Leases: soared 323.16% in 2022, then crashed 96.3% in 2025.
  • A 5-year view of Current Leases shows it stood at $2.4 million in 2021, then surged by 31.14% to $3.1 million in 2022, then soared by 56.03% to $4.9 million in 2023, then rose by 9.27% to $5.3 million in 2024, then crashed by 96.15% to $205000.0 in 2025.
  • Per Business Quant, the three most recent readings for BCYC's Current Leases are $205000.0 (Q4 2025), $5.2 million (Q2 2025), and $184000.0 (Q1 2025).